Delivery Order SPE2DB20D3101-SPE2DB23FRBQ8
Award Date 2/2/23
Potential Completion Date 2/3/23
Potential Value $5.1K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $3,082.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of NARCAN 4 mg nasal spray. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, with a ceiling value of $1,177.41 and a completion date of May 19, 2025. The contract is a Firm Fixed Price type with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of NARCAN 4 MG NASAL SPRAY 2S. The contract is a Delivery Order with a Firm Fixed Price pricing type and a ceiling value of $1,546.14. The contract has an ultimate completion date of July 16, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, with a ceiling value of $1,491.76 and a period of performance through March 11, 2024. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., and the contract was awarded as a delivery order without any set-aside designation. The company holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of NARCAN 4 MG NASAL SPRAY 2S. The firm-fixed-price contract has a ceiling value of $5,723.66 and an ultimate completion date of May 9, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of NARCAN 4 MG NASAL SPRAY 2S. The firm-fixed-price delivery order, valued at $4,097.74, has a completion date of February 8, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., the parent company. The contract is part of a larger Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical emergency medication used to treat opioid overdoses, to the Defense Logistics Agency (DLA). The contract, valued at $2,271.68, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of June 16, 2023 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of NARCAN 4 MG NASAL SPRAY 2S. The award, valued at $3,637.79, is a Firm Fixed Price delivery order with a completion date of December 27, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of NARCAN 4 MG NASAL SPRAY 2S. The contract, valued at $3,456.03, is a Firm Fixed Price Delivery Order with a period of performance through February 28, 2024. This contract is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $5,761.76 firm fixed price delivery order contract to supply NARCAN 4 MG NASAL SPRAY 2S. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 held by Amerisourcebergen Drug Corp, which serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical...